The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Mercer International Pops 50%, but Repros Therapeutics down 14%

 Aug 25, 2009 01:00 AM UTC
Stop
s J
Return Risk
-15.95% HIGH
Sr. Analyst
Symbol Sentiment Start Return Closed
HIMX n/a
MELA n/a
ARIA n/a
OTEX n/a
RPRX n/a
CPST n/a
TWI n/a
MERC n/a

Graphic_arrow1 Via Rant About It:  

Mercer International (MERC) 52% HIGHER; since announcing it's Q2 results on July 29, share of Mercer have skyrocketed more than 340%.

ARIAD Pharmaceuticals Inc. (ARIA) 5% HIGHER;
rose after the close on Friday. This morning's report was that ARIAD and its co-plaintiffs announced that the Court of Appeals granted their petition for rehearing 'En Banc' in the Lilly NF-kB patent lawsuit. Shares were up about 2% at $2.17 as many traders sold the news.

Electro-Optical Sciences, Inc. (MELA) 19% HIGHER; was a big winner after being featured in this weekend's "unusual suspects" after Barron's highlighted its skin cancer testing. Shares were up 20% at $9.53 ahead of the close and shares hit a new 52-week high above $10.00 earlier in the trading day.

Capstone Turbine Corp (CPST) 8% HIGHER; on receiving order worth more than $2 million

Repros Therapeutics (RPRX) 14.0% LOWER;
correcting today following a 50% jump on Friday. Shares have fallen below the $1 level today.

Titan International (TWI) 7.0% LOWER; announced earlier that it will halt output of its 13-foot tires as the company has said some of the tires have failed earlier at several oil-sands mines. The company has said it will resume output of this tire by the end of August.

ExpressJet Holdings Inc (XJET) crashed 12% LOWER

Himax Technologies (HIMX) dropped 10.5% LOWER


Open Text (OTEX) 5.5% LOWER; falling today following Thursday night's Q4 results and the ensuing wave of analyst calls.


 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch